William Enright serves as Executive at Altimmune, Inc., where they oversee executive responsibilities. Since joining the company, William Enright has executed 11 insider transactions totaling $57.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 22, 2025 involved receiving (via award) 2,813 shares valued at $0.
William Enright currently holds 13,523 shares of Altimmune, Inc. (NASDAQ:ALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Enright has been a net seller of NASDAQ:ALT stock. They have purchased $20.9K and sold $36.3K worth of shares.
William Enright's most recent insider trade was on Aug 22, 2025, when they sold 2,813 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 14, 2023 | BFRG,BFRGW | $20.3K | Purchase | 5,000 | $4.05 | Discretionary |
| Mar 27, 2023 | VACC | $36.3K | Sale | 15,000 | $2.42 | Discretionary |
| May 4, 2021 | VACC | $0 | Award | 514,923 | $N/A | Discretionary |
| Apr 29, 2021 | VACC | $0 | Award | 455,775 | $N/A | Discretionary |
| May 25, 2018 | ALT | $663 | Purchase | 1,300 | $0.51 | Discretionary |
| Jan 2, 2018 | ALT | $14.7K | Option Exercise | 183,347 | $0.08 | Discretionary |
| Aug 16, 2017 | ALT | $7.3K | Option Exercise | 91,733 | $0.08 | Discretionary |
| Aug 16, 2017 | ALT | $5.7K | Option Exercise | 71,644 | $0.08 | Discretionary |
| May 4, 2017 | NASDAQ:ALT | $0 | Award | 17,787 | $N/A | Discretionary |